Rho kinase inhibition: from hypertension to cardiovascular-renal remodeling and more

J Hypertens. 2022 Sep 1;40(9):1836-1837. doi: 10.1097/HJH.0000000000003156.

Authors

Lorenzo A Calò¹, Lucia Federica Stefanelli, Giovanni Bertoldi, Verdiana Ravarotto

Affiliation

¹ Nephrology, Dialysis and Transplantation Unit, Department of Medicine (DIMED), University of Padova, Padova, Italy.

PMID: 35943107
DOI: 10.1097/HJH.0000000000003156

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cardiovascular System*
Humans
Hypertension* / drug therapy
Kidney
Protein Kinase Inhibitors
rho-Associated Kinases

Substances

Protein Kinase Inhibitors
rho-Associated Kinases